Jump to content


  • Content count

  • Joined

  • Last visited

  • Days Won


About KLAW Blog

  • Rank
    Advanced Member

Profile Information

  • Location
    Supreme Leader Headquarters

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. PROCESSOR REMINDERS Applicants for processor operator licenses should take note of the following reminders via the Emergency Rules and the Medical Marihuana Facilities Licensing Act. This list is not all-inclusive and merely highlights some key areas that should be considered. A processor of edible marihuana product shall comply with CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKING, OR HOLDING HUMAN FOOD (located here) to ensure safe preparation – except that refrigerated potentially hazardous marihuana product must be stored at 4.4 degrees Celsius (40 degrees Fahrenheit) or below. The licensee shall provide employee training on safe food handling by providing either proof of ServSafe certification or documentation of employee training on food handling, including – but not limited to – allergens and proper sanitation and safe food handling techniques. A processor is prohibited from producing an edible marihuana product that requires time or temperature control for safety. The end-product must be a stable shelf-life edible marihuana product. A licensee shall comply with at least one of the following: FDA Food Safety Modernization Act (FSMA) 21 U.S.C. section 2201 et seq. Safe Quality Food-Code-Ed-7_2-Final-1-2014 International Organization for Standardization (ISO), ISO 22000/ISO/TS 22002-1 Upon licensure, the processor shall also include the following for all edible marihuana products: Allergen labeling as specified by federal labeling requirements. If any nutritional claim is made, appropriate labeling as specified by federal labeling requirements and these rules. A statement printed in at least the equivalent of 11-point font size in a color that provides a clear contrast to the background: “Made in a marihuana facility.” A processor’s edible marihuana product must comply with all the following: No edible marihuana product can be in a shape, color, package, or labeled in a manner that it would appeal to minors aged 17 years or younger. No edible marihuana product can be associated with or have cartoons, caricatures, toys, colors, designs, shapes, labels, or package that would appeal to minors. No edible marihuana product can be easily confused with commercially sold candy. The use of the word candy or candies on the packaging or labeling is prohibited. An edible marihuana product must be in child resistant packages or containers. Please follow this link for examples of prohibited packaging items. Upon licensure, a processor shall prepackage and properly label marihuana-infused products before sale or transfer. At a minimum, a processor shall label any marihuana-infused product it produces or packages with all the following: The name and address of the marihuana facility that processes or packages the marihuana infused product. The name of the marihuana-infused product. The ingredients of the marihuana-infused product, in descending order of predominance by weight. The net weight or net volume of the product. The THC level on the label along with the tag identification as required under these rules. See the LARA – PDF Release Here View the full article
  2. When can I apply for my license? What are the different licenses I can apply for? When will LARA stop taking applications? Beginning December 15, 2017, the Department of Licensing and Regulatory Affairs will begin taking applications for the following licenses: • Grower • Processor • Transporter • Provisioning Center • Safety Compliance Facility There is no deadline for submission. Komorn Law has represented numerous clients through the legal chaos of starting up a business in the Michigan Medical Marihuana Industry. Contact Us For More Information. 800-656-3557 View the full article
  3. Can a caregiver work in a licensed provisioning center, grow operation or other licensed facility and retain their caregiver status under MMMA? Grower and processor facility licensees are required under the MMFLA to have at least two years’ experience as a caregiver or have an active employee with that experience (this requirement ends on 12/31/21). However, a licensed grower or processor may not be registered as a caregiver and may not employ a registered caregiver. Secure transporters cannot be registered patients or caregivers. The MMFLA does not prohibit provisioning center and safety compliance facility licensees from being registered as patients or caregivers under the MMMA, nor does it prohibit these facilities from employing patients or caregivers. A licensee or an employee must submit the form to cancel their caregiver status within five business days. If a new employee is a caregiver, that person has 5 business days from their date of hire to submit the form to cancel caregiver status. The withdrawal form can be found at the Michigan Medical Marihuana Program website. Komorn Law has represented numerous clients through the legal chaos of starting up a business in the Michigan Medical Marihuana Industry. Contact Us For More Information. 800-656-3557 View the full article
  4. How do attorneys or other entities submit materials on someone else’s behalf? Third parties, such as CPAs, attorneys, etc., may create their own login for Accela, the facilities licensing application portal, and fill out applications and upload documents on behalf of their clients. Third parties will need to include documentation that establishes their authorization to submit on behalf of their clients. When can I apply for my license? What are the different licenses I can apply for? When will LARA stop taking applications? Beginning December 15, 2017, the Department of Licensing and Regulatory Affairs will begin taking applications for the following licenses: • Grower • Processor • Transporter • Provisioning Center • Safety Compliance Facility There is no deadline for submission. Can I apply for a facility license if I have marijuana medical card? Yes, you may apply for a facility license. Please refer to the advisory bulletin posted on November 17, 2017, for more information regarding that transition. Komorn Law has represented numerous clients through the legal chaos of starting up a business in the Michigan Medical Marihuana Industry. Contact Us For More Information. 800-656-3557 View the full article
  5. How does the application process work and who can apply for a license? Anyone — individual or business — who feels that they can satisfy statutory and administrative rule requirements for a marihuana facility license may apply for a license. The BMMR will begin accepting applications on December 15, 2017. There is no deadline to complete the application process. On December 15, 2017, LARA will begin accepting online or paper form applications, utilizing a two-step application process for medical marihuana facility licensing: Pre-Qualification License Qualification This two-step process will allow applicants to begin the application process by completing step one before a location for the medical marihuana facility is established. If applicants have a location secured, they will have the option of submitting step one and step two materials at the same time. Step One – Pre-Qualification The first step is Pre-Qualification which includes a full background check of the applicant and all supplemental applicants. This includes – but is not limited to – individuals or businesses with an ownership interest (direct or indirect) in the applicant. As part of the Pre-Qualification (step one), applicants must disclose those individuals and businesses with an indirect or direct ownership interest. Applicants should refer to Sections 401 and 404 of the MMFLA to determine which individuals or businesses must be included in the disclosure. Before an applicant’s Pre-Qualification (step one) materials can be reviewed, the applicant must pay the $6000 application fee. Until the $6000 application fee is paid, BMMR will not be able to process the application. After the application is processed, BMMR will notify applicants and supplemental applicants when and where fingerprints will be collected. Local law enforcement agencies will not collect fingerprints for BMMR and BMMR will not accept fingerprint reports completed by applicants before the applicants are instructed to have their fingerprints collected. Pre-Qualification (step one) may be completed before an applicant has a physical location for its business. Step Two – License Qualification The second step is the License Qualification. If applicants have a location secured, they will have the option of submitting step one and step two materials at the same time. License Qualification requires information specific to the physical location of the applicant’s business. An applicant cannot be issued a license until all requirements in the MMFLA and administrative rules are met. Under Section 205 of the MMFLA, the Department cannot issue a license to a facility intending to operate in a municipality unless the municipality has enacted an ordinance authorizing marihuana facilities to operate within the municipal boundaries. An applicant’s physical location will need to be located in a municipality with an ordinance compliant with Section 205 requirements. Any questions about municipal ordinances should be directed toward the appropriate municipal authority. While an application is being processed, staff of BMMR will be in communication with applicants regarding additional requirements in statute or administrative rule, including pre-licensure investigation. After notification of License Qualification (step two) approval from BMMR, an applicant will need to pay a regulatory assessment for each license the applicant is issued. Grower A license regulatory assessments are capped, by statute, at $10,000. The regulatory assessment for Grower B-C, Processor, Transporter, and Provisioning Center licenses will be dependent on the number of total licenses subject to assessment and could be as low as $10,000 or as high as $57,000. The exact amount of the regulatory assessment is not available at this time. There is no regulatory assessment for Safety Compliance Facilities. https://www.michigan.gov/lara/0,4601,7-154-78089_83746-454499–,00.html Komorn Law has represented numerous clients through the legal chaos of starting up a business in the Michigan Medical Marihuana Industry. Contact Us For More Information. 800-656-3557 View the full article
  6. The scientific name for cannabinoid is known as phytocannabinoid. The human endocannabinoid system is found throughout the body, dispersed within our connective tissue, glands, brain, immune cells and organs. Research has shown that receptors within this system react positively to cannabinoid compounds, resulting in a myriad of therapeutic benefits on the body. Some of the most effective cannabinoid compounds for the human body include: Tetrahydrocannabinol (THC) THC, also known as Delta(9)-tetrahydrocannabinol, is the primary psychoactive compound found within the cannabis plant. In other words, THC is the component known to make you ”high.” THC is a cannabinoid most commonly found in the female cannabis flower, but can also be found in the male plant. THC is only an acid compound with the cannabis plant and must be synthesized to harness its medicinal benefits. THC is not only effective as a psychoactive but is well-known for its benefits in managing chronic pain and other ailments. This cannabinoid is also known to help with the management of diseases such as Alzheimer’s, multiple sclerosis, Parkinson’s, Epilepsy, Cancer, Crohn’s disease, cancer, and PTSD. Tetrahydrocannabivarin (THCv) A sibling of THC, this is a form of cannabinoid that actually works simultaneously with the THC compound. THCv carries a far less potent psychoactive effect than THC however, with researchers claiming it yields about 20% of the same effect as THC. This cannabinoid is actually known to reduce some of the negative psychoactive effects of THC. Like many other cannabinoids, THCv works best in tandem with other cannabinoid components. Just some of the medicinal benefits of THCv include anti-convulsant properties, it works as a neuroprotective and helps to promote weight loss. Cannabidiol (CBD) The most famous and highly popularized of them all, cannabidiol, carries with it a host of incredible benefits on the body. This cannabinoid compound is not popular for no reason and is fast becoming a preferred form of treatment for many ailments, worldwide. Unlike THC, CBD does not carry psychoactive properties, making it all the more popular is it carries little to no side-effects. CBD has become incredibly popular because it allows its consumers to carry-out their everyday lives, while reaping the benefits of its healing properties. For many decades, medical cannabis has been overlooked as a form of treatment because of the negative stigma of its psychoactive properties. However, research has shown that its medicinal value is second-to-none, without experiencing any psychoactive side-effects. Currently, CBD can be consumed any many different forms including CBD oil, through vaping, CBD tablets or CBD ointment. This cannabinoid compound is being used to treat a plethora of illnesses, with great success. Some of these include epilepsy, cancer, chronic pain, migraine management, diabetes, cardiovascular disease, depression, anxiety and more. Cannabinol (CBN) Cannabinol may not be as well-known as both THC and CBD, but this cannabinoid also offers numerous health benefits. Cannabinol is not found in fresh cannabis flowers, but is actually derived from stale cannabis plant buds. This may sound bizarre, but as a cannabis plant ages, cannabinol develops and becomes all the more potent. Cannabinol is actually a broken down compound of THC, therefore it also offers psychoactive effects. Essentially, as THC ages, so cannabinol develops. If you leave cannabis plant buds to dry and age, the THC properties develop into what is known as CBN. While this cannabinoid is not necessarily ideal for everyday alertness and function, it has several health benefits: Stimulates the appetite – ideal for those undergoing chemotherapy or radiation treatment Works as an antibiotic Delays and eases symptoms of neural diseases such as ALS Chronic pain relief Potent anti-inflammatory properties Works as a natural sedative Lowers ocular pressure and helps with effects of glaucoma Despite its psychoactive properties which tend to carry a negative stigma, research has shown that CBN is an incredible natural alternative to a number of ailments. Cannabichromene (CBC) CBC is actually the third-most commonly used cannabinoid in the cannabis plant, rolling in after THC and CBD. In fact, CBC may have a higher prevalence in some cannabis strains over CBD. Just like its cousin, CBC does not carry any psychoactive properties. Despite this, CBC is known to be more effective as a medical treatment when combined with traces of THC. This suggests that cannabinoids prefer to work synergistically together. CBC has been found to offer a host of medicinal properties, including: Used as an effective anti-inflammatory. Helps to fight cancer-related tumors when combined other cannabinoids. Works as an anti-depressant. Carries anti-fungal properties. Help to encourage brain cell growth, which could help in the management of Alzheimer’s and dementia. While CBC itself carries these medicinal benefits, it is at its most powerful when combined with other cannabinoids, such as THC and CBD. Cannabigerol (CBG) CBD is also a distant cousin of CBD and carries no psychoactive effects, but a host of health benefits instead. CBG is a cannabinoid which is typically sourced in the early stages of growth in the cannabis plant. Just some of CBG’s health benefits include: An effective antimicrobial antibiotic, killing off various bacteria and fungi. Skin treatment – helping to reduce redness and sooth Psoriasis. CBG is a potent chronic pain reliever, said to be even stronger than THC. Helps to slow cancerous tumor growth – most specifically within the field of prostate cancer. Help to regular mood and acts as an anti-depressant. Due to its incredible medicinal properties, CBG is a hot topic among researchers and scientists today. If you currently suffer from any one of these common diseases or ailments, medical cannabis may just be the natural alternative you’re looking for: Heart disease Hypertension Diabetes Cancer – specifically breast or prostate cancer Parkinson’s Alzheimer’s Epilepsy Neuralgia Migraines or cluster headaches Skin disorders such as eczema or Psoriasis View the full article
  7. Cannabis produces a variety compounds known as cannabinoids, many of which have not been detected in any other plant. Most of them are present at very low levels, especially in commercial cannabis products, making it difficult for scientists to accurately detect them. 8 Cannabinoid Acids Produced by Cannabis Cannabis synthesizes several cannabinoid acids . These cannabinoid acids are created, usually by heat, to yield the compounds that most are after (THC or CBD). But in addition to THCA and CBDA, there are number of related cannabinoid acids that can be produced by Cannabis. These are: Click the item to read in depth detail from the .gov chemical database. CBGA (Cannabigerolic acid) THCA(Δ9-tetrahydrocannabinolic acid) CBDA (Cannabidiolic acid) CBCA (Cannabichromenenic acid) CBGVA (Cannabigerovarinic acid) THCVA (Tetrahydrocanabivarinic acid) CBDVA (Cannabidivarinic acid) CBCVA (Cannabichromevarinic acid) View the full article
  8. A scientific article on analyticalcannabis.com points out the main differences between Cannabidiol (CBD) and tetrahydrocannabinol (THC). It goes- Of the at least 113 cannabinoids that have been isolated to date, these two are undoubtedly the most well-known and, the most well researched. Cannabidiol (CBD) and tetrahydrocannabinol (THC) are both naturally occurring compounds found in plants in the cannabis genus. Known as phytocannabinoids, these compounds interact with CB1 and CB2 receptors found in the endocannabinoid system present in all mammalian species. CBD was first isolated in 1940 whilst THC was isolated in 1964 by the preeminent cannabis scientist Raphael Mechoulam. At the most fundamental level, THC and CBD are different because of their differing physiological effects. CBD is non-psychotropic and therefore does not illicit a “high” whereas THC is psychotropic and is the only known cannabis-derived compound to illicit a “high”. Here we look at some of the key differences, and similarities, between CBD and THC. To read the rest of the article follow the link below https://www.analyticalcannabis.com/articles/cbd-vs-thc-what-are-the-main-differences-297486 Here is the PDF if the link is broken View the full article
  9. Recreational marijuana use will soon be legal in Canada after the Senate passed a “historic” bill on Tuesday 6/19/18 with a vote of 52-29. Canada is the second country in the world to implement legislation to permit a nationwide marijuana market. Uruguay was the first country to legalize marijuana’s production, sale and consumption in December 2013. Read the law and regulation-if you can here In the neighboring US, nine states and the District of Columbia now allow for recreational marijuana use, and 30 allow for medical use. The act to legalize the recreational use of marijuana was introduced on April 13, 2017, and was later passed at the House of Commons in November. The Senate passage of the bill was the final hurdle in the process. Bill C-45, AKA…The Cannabis Act, stems from a campaign pledge of Prime Minister Justin Trudeau to keep marijuana away from underage users and reduce related crime. Although the Canadian government had initially stated its intent to implement by July 2018, provinces and territories and who would be responsible for drafting their own rules for marijuana sales. They have advised that they would need eight to 12 weeks after the Senate approval to transition to the new framework. The government is expected to choose a date in early or mid September. View the full article
  10. Senators Ron Wyden, D-Oregon, Mitch McConnell, R-Ky., Jeff Merkley, D-Oregon, and Rand Paul, R-Ky., cheered the passage of their bipartisan Senate resolution designating June 4-10 “Hemp History Week.” View the full article
  11. A mother with no criminal record of 4 separated from her family and children after being jailed for vitamins being mistaken for drugs in a widely used drug test kit by police. These Duquenois Levine reagent tests for marijuana will test positive for most any substances, candies, even the air will make them change color and false positive alert for a controlled substance. Never consent to a search by a police officer. Tell the officer you do not consent to a search and ask if you are free to go. Don’t answer any questions , tell the officer you want your lawyer present during any questioning. These important phrases will keep you out of trouble and protect your constitutional rights! View the full article
  12. LANSING — The Michigan Medical Marijuana Licensing Board was supposed to give out the first licenses to cannabis businesses next week. But those businesses will have to wait another month before they can open their doors after Monday’s meeting was cancelled on Friday. The cancellation came after one board member said they couldn’t make the meeting and another said they would have a difficult time making it there in time. David Harns, spokesman for the state Department of Licensing and Regulation, wouldn’t reveal which members weren’t able to attend. The board was set to award licenses to four applicants that represent four large marijuana growing operations, a secure transport company, a dispensary in Ann Arbor and a processor. They also were supposed to consider pre-qualifying 10 applicants for a variety of medical marijuana businesses. Read the rest of the story here View the full article
  13. Sponsor: Sen. Booker, Cory A. [D-NJ] (Introduced 08/01/2017) Committees:Senate – Judiciary Latest Action:Senate – 08/01/2017 Read twice and referred to the Committee on the Judiciary. (All Actions) Shown Here: Introduced in Senate (08/01/2017) Marijuana Justice Act of 2017 This bill amends the Controlled Substances Act: to remove marijuana and tetrahydrocannabinols from schedule I; and to eliminate criminal penalties for an individual who imports, exports, manufactures, distributes, or possesses with intent to distribute marijuana. It prohibits and reduces certain federal funds for a state without a statute legalizing marijuana, if the Bureau of Justice Assistance determines that such a state has a disproportionate arrest rate or disproportionate incarceration rate for marijuana offenses. The bill directs federal courts to expunge convictions for marijuana use or possession. Finally, it establishes in the Treasury the Community Reinvestment Fund. Amounts in the fund may be used by the Department of Housing and Urban Development to establish a grant program to reinvest in communities most affected by the war on drugs. View the full article
  14. June 12, 2018 The Detroit News Detroit — City officials are considering a new proposal that would cap the number of medical marijuana facilities operating in the city to 75 and lay out regulations for where they can locate. The ordinance, which also includes provisions for how large the operations can be, is the latest by Detroit to combat a proliferation of so-called pot shops in the city in recent years. Detroit City Councilman James Tate submitted the zoning ordinance changes last month to the City Planning Commission for a review and recommendation. The ordinance will then be introduced for council’s consideration. The legislation would establish rules for facilities in Detroit that grow, test, process, transport and dispense medical marijuana to patients with state-approved medical marijuana cards. It also would encourage medical marijuana operators to provide community benefits in their licensing operations, city officials said. “The goal has always been to ensure that we have an industry that is respectful of the neighborhoods, the communities it is located in, but also considerate to individuals seeking safe access to alternative medication,” Tate said in a statement. “This ordinance balances those two needs with the preservation of neighborhoods being the top priority.” Read more Christine Ferretti, The Detroit News Published 2:19 a.m. ET June 12, 2018 View the full article
  15. Jun 13, 12:16 PM ROSS TOWNSHIP, MI — Residents of a rural township in Kalamazoo County are breathing a bit easier as their organized resistance to medical marijuana appears to be paying off. Tuesday, the Ross Township Board of Trustees repealed an ordinance that legalizes medical marijuana facilities and sets a process for obtaining permission to open them. A second ordinance dealing with the zoning districts marijuana businesses can open was not repealed. Supervisor Gary Moore said the township is going to “take a step back, revisit and take another swing” at creating marijuana ordinances that align with the community’s interests. The Planning Commission will be charged with reexamining the zoning districts where marijuana facilities could open. “Ross Township is a good community and we are going to work our way through this,” Moore said. Kalamazoo County Clerk Tim Snow said he was notified by residents that a petition to recall the township board would be turned in to his office Wednesday afternoon. Read more By Malachi Barrett View the full article